Torrey Pines Investment

Today, Rustam Minnikhanov, the Head of Tatarstan, met in San Francisco with Nikolay Savchuk, the managing partner of Torrey Pines Investment, as reported by the Tatarstan President’s press service.

Torrey Pines Investment is a venture company specializing in investment in the field of medical and biological technology. Today, their venture portfolio includes 16 companies; their development is aimed at application in various therapeutic areas – the treatment of the HIV, central nervous system diseases, oncological diseases, viral infections, etc.

The parties discussed the issues of their further cooperation in healthcare and pharmaceuticals, including the interaction between Torrey Pines Investment and Tatkhimfarmpreparaty, OJSC.

24 October 2017

American Venture Company Torrey Pines Investment is ready to create a joint venture with Tatkhimpharmpreparaty OJSC to produce innovative medicines in Tatarstan.

21 April 2016
Tatarstan republic

Investor profile

Torrey Pines Investment


Company's website:

T: (858) 724-0581

Private company


Contact: Ronald M.B.S. Demuth, President

Torrey Pines Investment focuses on investments in the field of medical and biological technologies. Currently, there are 16 companies in its venture portfolio. Their developments aim at use in various therapeutic areas such as treatment of HIV infection, central nervous system diseases, cancer, viral infections, etc. The total assets managed by the company amount to more than $ 500 million.